Next Article in Journal
Impact of Gravity on Thyroid Cells
Next Article in Special Issue
A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro
Previous Article in Journal
miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4
Previous Article in Special Issue
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
Open AccessReview

Nanomedicine Strategies to Target Tumor-Associated Macrophages

Targeted Therapeutics, Biomaterials Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7522NB Enschede, The Netherlands
Department of Pharmaceutics, Utrecht University, 3584CS Utrecht, The Netherlands
Author to whom correspondence should be addressed.
Academic Editor: Li Yang
Int. J. Mol. Sci. 2017, 18(5), 979;
Received: 4 April 2017 / Revised: 25 April 2017 / Accepted: 1 May 2017 / Published: 4 May 2017
(This article belongs to the Special Issue Tumor Microenvironment and Metabolism)
In recent years, the influence of the tumor microenvironment (TME) on cancer progression has been better understood. Macrophages, one of the most important cell types in the TME, exist in different subtypes, each of which has a different function. While classically activated M1 macrophages are involved in inflammatory and malignant processes, activated M2 macrophages are more involved in the wound-healing processes occurring in tumors. Tumor-associated macrophages (TAM) display M2 macrophage characteristics and support tumor growth and metastasis by matrix remodeling, neo-angiogenesis, and suppressing local immunity. Due to their detrimental role in tumor growth and metastasis, selective targeting of TAM for the treatment of cancer may prove to be beneficial in the treatment of cancer. Due to the plastic nature of macrophages, their activities may be altered to inhibit tumor growth. In this review, we will discuss the therapeutic options for the modulation and targeting of TAM. Different therapeutic strategies to deplete, inhibit recruitment of, or re-educate TAM will be discussed. Current strategies for the targeting of TAM using nanomedicine are reviewed. Passive targeting using different nanoparticle systems is described. Since TAM display a number of upregulated surface proteins compared to non-TAM, specific targeting using targeting ligands coupled to nanoparticles is discussed in detail. View Full-Text
Keywords: nanoparticles; macrophages; tumor-associated macrophages; passive targeting; active targeting; cancer nanoparticles; macrophages; tumor-associated macrophages; passive targeting; active targeting; cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Binnemars-Postma, K.; Storm, G.; Prakash, J. Nanomedicine Strategies to Target Tumor-Associated Macrophages. Int. J. Mol. Sci. 2017, 18, 979.

AMA Style

Binnemars-Postma K, Storm G, Prakash J. Nanomedicine Strategies to Target Tumor-Associated Macrophages. International Journal of Molecular Sciences. 2017; 18(5):979.

Chicago/Turabian Style

Binnemars-Postma, Karin; Storm, Gert; Prakash, Jai. 2017. "Nanomedicine Strategies to Target Tumor-Associated Macrophages" Int. J. Mol. Sci. 18, no. 5: 979.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop